FOXP4 and thyroid gland papillary carcinoma: We can see from Figure 1A that lncRNA FOXP4-AS1 was drastically decreased in papillary thyroid carcinoma clinical samples compared to normal samples by reverse transcription-quantitative polymerase chain reaction (qRT-PCR) assay.